VTGN — Vistagen Therapeutics, Inc.

VTGNVistagen Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · vistagen.com

0.6371USD-1.98%Mkt Cap: 25.35M USDP/E: —Last update: 2026-05-26

Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline inclu…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap25.35M USD

Enterprise Value-35.10M USD

Revenue (TTM)789.00K USD

Gross Profit789.00K USD

Net Income (TTM)-51.42M USD

Revenue/Share0.0220 USD

Last Price0.6371 USD

Fiscal Year EndMar 2025

MR QuarterDec 2025

Employees59

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.56

PEG—

EV/EBITDA0.50

EV/Revenue-44.49

P/S31.99

P/B0.50

EPS (TTM)-1.90

EPS (Forward)-1.13

52W Range

0.43004% of range5.140

52W High5.140 USD

52W Low0.4300 USD

Profitability

Gross Margin100.00%

Oper. Margin-6450.83%

EBITDA Margin0.00%

Profit Margin-10579.84%

ROE-73.05%

ROA-60.96%

Growth

Revenue Growth29.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-42.10M USD

CapEx (TTM)191.00K USD

FCF Margin-4583.90%

FCF Yield-142.70%

Net Debt-60.34M USD

Net Debt/EBITDA0.87

Balance Sheet

Debt/Equity0.02

Current Ratio4.67

Quick Ratio4.57

Book Value/Sh1.285 USD

Cash/Share1.559 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:30

Split DateJun 7, 2023

Analyst Consensus

Rating3.0 (Hold)

Target (Mean)0.9667 USD

Target Range0.9000 USD – 1.000 USD

# Analysts3

Ownership

Shares Out.39.62M

Float33.78M

Insiders0.27%

Institutions42.26%

Short Interest

Short Ratio2.0d

Short % Float6.33%

Short % Out.4.44%

Shares Short1.76M

Short (prev mo.)1.41M

Technical

SMA 500.6046 (+5.4%)

SMA 2002.083 (-69.4%)

Beta0.30

S&P 52W Chg28.31%

Avg Vol (30d)1.02M

Avg Vol (10d)1.30M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—